Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alan Menter

Showing results (61-70 of 298) with videos related to

Pageof 30
Sort By:
Journal of the American Academy of Dermatology|January 17, 2004
Methotrexate and psoriasis in the era of new biologic agentsFrank C Saporito, M Alan Menter
Pediatric Dermatology|February 12, 2004
Successful treatment of pediatric psoriasis with infliximabM Alan Menter, John M Cush
Cutis|August 1, 2008
One-week treatment with once-daily fluorouracil cream 0.5% in participants with actinic keratosesAlan Menter, George Vamvakias, Joseph Jorizzo
Dermatologic Clinics|September 29, 2004
Practical considerations in future psoriasis therapiesChristy Riddle, Melodie Young, Alan Menter
Therapeutic Delivery|June 30, 2017
Calcipotriene betamethasone dipropionate aerosol foam in the treatment of plaque psoriasis: a review of the literatureJillian Frieder, Dario Kivelevitch, Alan Menter
Journal of the American Academy of Dermatology|June 26, 2012
Psoriasis, hepatitis B, and the tumor necrosis factor-alpha inhibitory agents: a review and recommendations for managementAmanda Abramson, Alan Menter, Robert Perrillo
Journal of the American Academy of Dermatology|November 25, 2010
The use of cyclosporine in dermatology: part IKarrie T Amor, Caitriona Ryan, Alan Menter
Journal of Drugs in Dermatology : JDD|June 20, 2008
Psoriasis and the metabolic syndromeAlice B Gottlieb, Frank Dann, Alan Menter
Journal of the American Academy of Dermatology|September 16, 2014
The use of tumor necrosis factor inhibitors in pregnancy: what is the evidence?Dario Nicolas Kivelevitch, Caitriona Ryan, Alan Menter
Circulation|July 19, 2017
Coronary Plaque Characterization in PsoriasisDario Kivelevitch, Jeffrey M Schussler, Alan Menter
Pageof 30

Showing results (61-70 of 298) with videos related to

Sort By:
Pageof 30
Journal of the American Academy of Dermatology|January 17, 2004
Methotrexate and psoriasis in the era of new biologic agentsFrank C Saporito, M Alan Menter
Pediatric Dermatology|February 12, 2004
Successful treatment of pediatric psoriasis with infliximabM Alan Menter, John M Cush
Cutis|August 1, 2008
One-week treatment with once-daily fluorouracil cream 0.5% in participants with actinic keratosesAlan Menter, George Vamvakias, Joseph Jorizzo
Dermatologic Clinics|September 29, 2004
Practical considerations in future psoriasis therapiesChristy Riddle, Melodie Young, Alan Menter
Therapeutic Delivery|June 30, 2017
Calcipotriene betamethasone dipropionate aerosol foam in the treatment of plaque psoriasis: a review of the literatureJillian Frieder, Dario Kivelevitch, Alan Menter
Journal of the American Academy of Dermatology|June 26, 2012
Psoriasis, hepatitis B, and the tumor necrosis factor-alpha inhibitory agents: a review and recommendations for managementAmanda Abramson, Alan Menter, Robert Perrillo
Journal of the American Academy of Dermatology|November 25, 2010
The use of cyclosporine in dermatology: part IKarrie T Amor, Caitriona Ryan, Alan Menter
Journal of Drugs in Dermatology : JDD|June 20, 2008
Psoriasis and the metabolic syndromeAlice B Gottlieb, Frank Dann, Alan Menter
Journal of the American Academy of Dermatology|September 16, 2014
The use of tumor necrosis factor inhibitors in pregnancy: what is the evidence?Dario Nicolas Kivelevitch, Caitriona Ryan, Alan Menter
Circulation|July 19, 2017
Coronary Plaque Characterization in PsoriasisDario Kivelevitch, Jeffrey M Schussler, Alan Menter
Pageof 30